123 related articles for article (PubMed ID: 6362467)
1. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal.
Borg S; Czarnecka A; Kvande H; Mossberg D; Sedvall G
Alcohol Clin Exp Res; 1983; 7(4):411-5. PubMed ID: 6362467
[TBL] [Abstract][Full Text] [Related]
2. Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers.
Borg S; Kvande H; Sedvall G
Science; 1981 Sep; 213(4512):1135-7. PubMed ID: 7268421
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system noradrenaline metabolism and alcohol consumption in man.
Borg S; Kvande H; Mossberg D; Valverius P; Sedvall G
Pharmacol Biochem Behav; 1983; 18 Suppl 1():375-8. PubMed ID: 6634849
[TBL] [Abstract][Full Text] [Related]
4. Biochemical investigations into the alcoholic delirium: alterations of biogenic amines.
Athen D; Beckmann H; Ackenheil M; Markianos M
Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):129-40. PubMed ID: 921518
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical studies in delirium tremens (author's transl)].
Athen D; Beckmann H; Ackenheil M; Markianos E
Arzneimittelforschung; 1978; 28(9):1527-8. PubMed ID: 582551
[TBL] [Abstract][Full Text] [Related]
7. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4.
Calderini G; Morselli PL; Garattini S
Eur J Pharmacol; 1975 Dec; 34(2):345-50. PubMed ID: 1234553
[TBL] [Abstract][Full Text] [Related]
8. [Physiological role and clinical significance of 3-methoxy-4-hydroxyethyleneglycol, a noradrenaline metabolite (review of the literature)].
Bol'shakova TD; Shenderovich MIa
Vopr Med Khim; 1987; 33(6):3-11. PubMed ID: 3328414
[TBL] [Abstract][Full Text] [Related]
9. Delirium tremens and related clinical states: changes in calcium and inorganic phosphate concentrations in plasma and cerebrospinal fluid.
Kramp P; Hemmingsen R
Acta Psychiatr Scand; 1984 Mar; 69(3):250-8. PubMed ID: 6711351
[TBL] [Abstract][Full Text] [Related]
10. Organic cerebral reactions in alcoholism: psychobiological aspects of treatment.
Hemmingsen R; Kramp P; Rafaelsen OJ
Subst Alcohol Actions Misuse; 1983; 4(2-3):225-34. PubMed ID: 6139882
[TBL] [Abstract][Full Text] [Related]
11. Impaired water excretion and elevated plasma vasopressin in patients with alcohol-withdrawal symptoms.
Emsley RA; Potgieter A; Taljaard JJ; Coetzee D; Joubert G; Gledhill RF
Q J Med; 1987 Aug; 64(244):671-8. PubMed ID: 3444873
[TBL] [Abstract][Full Text] [Related]
12. The effect of acute alcohol withdrawal on the serum potassium and total body potassium in heavy drinkers.
Watson WS; Lawson PM; Beattie AD
Scott Med J; 1984 Oct; 29(4):222-6. PubMed ID: 6241747
[TBL] [Abstract][Full Text] [Related]
13. Plasma immunoreactive insulin and somatotropin in delirium tremens and alcoholic hallucinosis.
DobrzaĆski T; Pieschl D
J Stud Alcohol; 1976 Mar; 37(3):327-33. PubMed ID: 4667
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical correlates of sympathetic activation during severe alcohol withdrawal.
Hawley RJ; Nemeroff CB; Bissette G; Guidotti A; Rawlings R; Linnoila M
Alcohol Clin Exp Res; 1994 Dec; 18(6):1312-6. PubMed ID: 7695023
[TBL] [Abstract][Full Text] [Related]
15. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
Dolphin A; Jenner P; Marsden CD
J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
[No Abstract] [Full Text] [Related]
16. Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG).
Keeton TK; Krutzsch H; Lovenberg W
Science; 1981 Feb; 211(4482):586-8. PubMed ID: 7455697
[TBL] [Abstract][Full Text] [Related]
17. Short and long-term effects of reserpine on the concentration of 1-(4-hydroxy-3-methoxyphenyl)-ethane-1,2-diol (MOPEG-SO4) in the brain of the rat.
Bareggi SR; Genovese E; Markey K
Br J Pharmacol; 1979 Apr; 65(4):573-8. PubMed ID: 435682
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in cerebral noradrenaline turnover in mice withdrawn from repeated morphine treatment and tolerance to the effects of acute morphine.
Airio J; Attila M; Ahtee L
Pharmacol Toxicol; 1995 Sep; 77(3):196-203. PubMed ID: 8884883
[TBL] [Abstract][Full Text] [Related]
19. Magnesium concentrations in blood and cerebrospinal fluid during delirium tremens.
Kramp P; Hemmingsen R; Rafaelsen OJ
Psychiatry Res; 1979 Oct; 1(2):161-71. PubMed ID: 298346
[TBL] [Abstract][Full Text] [Related]
20. Effects of single and multiple doses of desipramine (DMI) on endogenous levels of 3-methoxy-4-hydroxyphenylglycol-sulfate (MOPEG-SO4) in rat brain.
Bareggi SR; Markey K; Genovese E
Eur J Pharmacol; 1978 Aug; 50(4):301-6. PubMed ID: 699958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]